OrfoNeuro ApS is a Danish APS based in Lynge, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2016, the company reported a gross profit of -DKK 267.6k in its latest annual filing.
Selskabet tegnes af den samlede direktion eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at investere i lægemidler og forestå udviklingen af sådanne, enten direkte eller indirekte og enten alene eller i samarbejde med andre samt at fungere som holdingselskab for selskaber indenfor disse områder.
In its most recent annual report (2025), OrfoNeuro ApS reported a gross profit of -DKK 267.6k. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 289.7k.
At the end of 2025, equity financed 11.7% of the balance sheet, and current assets covered short-term debt 1 times.
Frequently asked questions
What is the CVR number of OrfoNeuro ApS?
OrfoNeuro ApS is registered with CVR / Virk under CVR 37768901.
What is the gross profit of OrfoNeuro ApS?
OrfoNeuro ApS reported a gross profit of -DKK 267.6k in 2025.
Who is the chairman of OrfoNeuro ApS?
Ulrik Spork chairs the board of OrfoNeuro ApS, in role since 2025.
Where is OrfoNeuro ApS headquartered?
OrfoNeuro ApS's registered address is Bjergagervej 37.
